News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
New Drugs in Low-Risk MDS: Where do we Stand? – IACH
Talha Badar/X
Feb 11, 2025, 07:26

New Drugs in Low-Risk MDS: Where do we Stand? – IACH

IACH shared a post on X:

“Don’t miss the upcoming IACH webinar:

New Drugs in Low-Risk MDS: Where do we Stand?
with Dr. Talha Badar

Date: Thursday, Feb 13 2025
Time: 5:30pm CET

Registration is FREE
click to join.”

Low-risk MDS

cancer IACH MDS OncoDaily Oncology Talha Badar
Special Coverage
Opinion
Apr 19, 2025, 01:47
Essential Medicines for Children with Cancer: From Access to Action – A Powerful OncoDaily Virtual Forum
Opinion
Apr 19, 2025, 01:45
Dr. Don Dizon and Dr. Nathan Pennell Reflect on the Evolution of the ASCO Educational Book
Blog
Apr 19, 2025, 01:45
Shray Saheba: I had the exciting opportunity to present my research at the National Research Conference hosted by Brown University
Blog
Apr 19, 2025, 01:42
Highlights from Brown University's Inaugural National Undergraduate Research Conference
Blog
Apr 19, 2025, 01:22
National Cancer Control Plans ensures better prevention, early diagnosis and treatment for all - UICC
Blog
Apr 19, 2025, 01:19
Milos Grujic: Patient-Reported Outcomes with Talazoparib plus Enzalutamide
Science
Apr 19, 2025, 01:13
Filipe Nadir Caparica Santos: The potential of internationally trained physicians
Blog
Apr 19, 2025, 01:05
Join ESTRO 2025 for a series of debate sessions on radiation oncology
Blog
Apr 19, 2025, 01:00
Norman Ng: Joanne Chiu discusses the remarkable advancements in cancer treatment and the potential for long-term survival
Blog
Apr 19, 2025, 00:20
Heba ElNokoudy: Comprehensive patient counseling significantly reduces adverse drug events
Blog
Apr 18, 2025, 20:22
Applications are open for the ESMO Research Fellowship
Blog
Apr 18, 2025, 20:12
Caitríona Duggan: Delighted for the opportunity to share our work at MASCC